Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 3Glioblastoma 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Osteonecrosis 1Osteomyelitis 1Neurodegenerative Diseases 1Malignant Solid Neoplasm 1Kidney Neoplasms 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Head and Neck Neoplasms 1Glioma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Childhood Brain Neoplasm 1Central Nervous System Vascular Malformations 1Central Nervous System Infections 1Carcinoma, Medullary 1Cancer of Lymph Node 1

Interventions

Gadolinium 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adult Brain Glioblastoma × Ferrosoferric Oxide × Clear all
NCT00660543 2017-05-16

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

OHSU Knight Cancer Institute

Phase NA Completed
14 enrolled 6 charts
CNS

Adult Brain Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡